EPRXEupraxia Pharmaceuticals Inc.TSXHealth Care
C$9.57−C$1.08Down10.14%Oct 26, 2026 close
Coming Soon
Format:
METRIC
TTM
Dec 25
Dec 24
Dec 23
Period Ending—Dec 31, 2025Dec 31, 2024Dec 31, 2023
Revenue
Revenue$0.00M$0.00M$0.00M$0.00M
Cost of Revenue————
Gross Profit————
Operating
Operating Income-$57.1M-$38.4M-$27.0M-$27.8M
EBITDA-$56.7M-$38.2M-$26.8M-$27.7M
Pre-Tax Income-$50.2M-$38.6M-$25.7M-$28.9M
Income Tax Expense$0.06M$0.02M$0.00M$0.04M
Net Income-$50.2M-$38.6M-$25.5M-$28.2M
Per Share
EPS (Basic)$-1.04$-1.03$-0.76$-1.17
EPS (Diluted)$-1.04$-1.03$-0.76$-1.17
Shares Basic48.5M40.0M33.9M24.1M
Shares Diluted48.5M40.0M33.9M24.1M
Dividend Per Share————
Margins
Gross Margin————
EBIT Margin————
EBITDA Margin————
Net Margin————
Effective Tax Rate-0.1%-0.0%-0.0%-0.1%
Growth
Revenue Growth————
Net Income Growth—-51.3%+9.6%-52.6%
EPS Growth—-35.5%+35.0%-21.9%
Share Count Change—+17.8%+40.5%+25.2%
Free Cash Flow
Free Cash Flow-$38.2M-$29.1M-$30.1M-$20.8M
FCF Per Share$-0.79$-0.73$-0.89$-0.86
FCF Margin————
FCF Growth—+3.2%-44.6%-42.3%
© 2026 WallStMonk. All rights reserved. v0.19.39Not investment advice · Data as of previous market close